Cite
HARVARD Citation
Shore, N. et al. (2017). Polymer‐delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open‐label studies in patients with advanced prostate cancer. BJU international. pp. 239-244. [Online].